arbekacin has been researched along with Burns in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, M; Katayama, S; Kawada, K; Momose, Y; Nishizawa, K; Takehira, R; Yamamura, S | 2 |
| Kim, JH; Lah, HO; Yim, DS | 1 |
1 trial(s) available for arbekacin and Burns
| Article | Year |
|---|---|
Artificial neural network modeling to predict the plasma concentration of aminoglycosides in burn patients.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Burns; Dibekacin; Female; Fluorescence Polarization Immunoassay; Humans; Infusions, Intravenous; Linear Models; Logistic Models; Male; Middle Aged; Neural Networks, Computer | 2004 |
2 other study(ies) available for arbekacin and Burns
| Article | Year |
|---|---|
Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Blood Glucose; Burns; Creatinine; Dibekacin; Female; Forecasting; Humans; Logistic Models; Male; Methicillin Resistance; Middle Aged; Neural Networks, Computer; Retrospective Studies; Severity of Illness Index; Skin Transplantation; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
Population pharmacokinetics of arbekacin in burn patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Burns; Dibekacin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Retrospective Studies | 2008 |